Abstract:AIM: To observe the change of the ratio of ligand of receptor activator of NF-κB (RANKL) and osteoprotegerin (OPG) by inhibiting the expression RANKL with RNA interference (RNAi), and explore the relationship between osteoblast and osteoclastogenesis. METHODS: The experiment was conducted in the laboratory of Transplantation Immunity of West China Hospital, Sichuan University from May to October 2006. ①Four chemically synthesized small interfering RNA (siRNA) targeting RANKL were transfected into osteoblast using Lipofectamin 2000TM.②RANKL mRNA level was determined by real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR), and the most effective siRNA was screened. ③Three groups including the most effective siRNA transfecting group, negative control group, and blank control group were established and each group involved 5 specimens. Meanwhile, the immunohistochemistry was employed to analyze the expression of RANKL and OPG in osteoblasts, and then the change of ratio of RANKL and OPG was observed. ④The transfected cells of the above three groups and primary rat bone marrow cells were co-cultured to explore the osteoclastogenesis induced by osteoblast. RESULTS: ①The most effective sequence was found out among the 4 candidates. Single dose of siRNA 4 caused nearly 89% loss of RANKL mRNA compared with the blank control group. siRNA1 and siRNA3 reduced the expression of RANKL mRNA to below 50%, and siRNA2 could also efficiently inhibit the expression of RANKL mRNA. ②The positive expressions of RANKL and OPG protein displayed buffy granules which of RANKL were distributed at endochylema and membrane and which of OPG at endochylema. The expression of RANKL protein of siRNA4 transfecting group was lower than that of the blank control group (average integral optical density: 3.05±2.17, 11.31±1.26, respectively), and the differences were significant statistical (P < 0.01); There was no significant difference in the expression of RANKL protein between the negative control group and the blank control group (P > 0.05). And there was no significant difference in the expression of OPG protein among three groups (P > 0.05). The ratio of RANKL/OPG of siRNA4 transfecting group was lower than that of the blank control group (0.12±0.03, 0.45±0.04), and there were obvious differences. ③ The morphous of co-cultured osteoclasts were similar to that of the isolated mature osteoclasts, irregular shape, red-dyed kytoplasm, and pseudopod. The osteoclast number of siRNA4 transfecting group was significantly lower than that of the blank and negative control groups (12±2), (31±7), (28±5) cells per well, P < 0.01, and there was no significant difference between the negative control group and the blank control group (P > 0.05). CONCLUSION: RANKL silenced by RNAi could reduce the ratio of RANKL/OPG and inhibit the formation of osteoclast.

Effects of phosphodiesterase 7 inhibition by RNA interference on the gene expression and differentiation of human mesenchymal stem cell-derived osteoblasts

Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation

Effects of RNA interference targeting PPARγ gene on adipogenic and osteogenic potential of mouse bone marrow stem cells

TRANSFECTION OF HMSCS WITH CHEMICALLY MODIFIED MRNA CODING FOR BMP-7 ENHANCES OSTEOGENESIS

Effects of Receptor Activator of NF-κB Ligand Gene Silencing on the Human Osteoblast-Like MG63 Cells

The Influence of Tetracycline Inducible Targeting Rat PPARγ Gene Silencing on the Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells.

Effect of ANGPTL7 on Proliferation and Differentiation of MC3T3-E1 Cells

MicroRNA Hsa-Let-7b Regulates the Osteogenic Differentiation of Human Periodontal Ligament Stem Cells by Targeting CTHRC1.

Regulation of the Osteogenic and Adipogenic Differentiation of Bone Marrow-Derived Stromal Cells by Extracellular Uridine Triphosphate: the Role of P2y2 Receptor and Erk1/2 Signaling

Effects of Rhbmp-7 on Osteoblast Differentiation of Murine Bone Marrow Mesenchymal Stem Cells in Vitro

Circular RNA CDR1as regulates osteoblastic differentiation of periodontal ligament stem cells via the miR-7/GDF5/SMAD and p38 MAPK signaling pathway

Inhibition of Osteoclastogenesis by RNA Interference Targeting RANK

MicroRNA-483-5p inhibits osteogenic differentiation of human bone marrow mesenchymal stem cells by targeting the RPL31-mediated RAS/ MEK/ERK signaling pathway

Effect of silencing ligand of receptor activator of NF-kappaB expression by RNA interference on osteoclastogenesis induced by osteoblast

Effect of Bone Morphogenetic Protein 2 Sirna Targeted Suppression on Osteogenic Differentiation and Calcification of Human Umbilical Arterial Smooth Muscle Cells Cultured in Vitro

Polydeoxyribonucleotide ameliorates IL-1β-induced impairment of chondrogenic differentiation in human bone marrow-derived mesenchymal stem cells

MICRO RNA-451 PROMOTING OSTEOGENESIS OF MESENCHYMAL STEM CELLS BY TARGETING REGULATORY CALCIUM BINDING PROTEIN 39

Role of P2X7 Receptor in the Osteogenic Differentiation of Bone Marrow Stromal Cells Induced by Electromagnetic Fields

Effect of targeting regulation of Smad3 by miR-145 on the osteogenic differentiation of human bone marrow mesenchymal stem cells

Effects of neotype bone morphogenetic protein-7 peptide on biological behavior of bone marrow stromal stem cells

Differential Effects of PTH (1-34), PTHrP (1-36), and Abaloparatide on the Murine Osteoblast Transcriptome